Press Release Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…Expansion TherapeuticsNovember 13, 2018
Press Release Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases Names Kevin M. Forrest, Ph.D. President and CEO Proprietary technology based on pioneering work from…Expansion TherapeuticsJanuary 3, 2018
